BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

BioTech Health X

803 posts

Biotech NewsFrom $0 to $300M+ in Sales: Mirum Pharmaceuticals (MIRM)’s Wild Ride Is Just Beginning

  • BioTech Health X
  • August 6, 2025
Mirum Pharmaceuticals (NASDAQ:MIRM) continues to intrigue growth-focused investors despite trading at a relatively low price-to-sales (P/S) ratio of…
0 Shares
0
0
0
0
0
0
0

Biotech NewsNutriband (NTRB): The #1 Biotech That Could 10x by Solving America’s Opioid Problem

  • BioTech Health X
  • August 5, 2025
Nutriband Inc. (NASDAQ:NTRB) is a forward-thinking pharmaceutical company dedicated to transforming the safety and accessibility of transdermal drug…
0 Shares
0
0
0
0
0
0
0

Biotech NewsBig Pharma Should Be Nervous — Xeris (XERS) Just Cracked the Code on Drug Delivery

  • BioTech Health X
  • August 5, 2025
Xeris Biopharma Holdings Inc. (NASDAQ:XERS) is a specialty pharmaceutical company dedicated to unlocking the full potential of therapeutics…
0 Shares
0
0
0
0
0
0
0

Biotech NewsD-Wave (QBTS) Just Changed the Game for AI — And Their Stock May Be the Next 10X Winner

  • BioTech Health X
  • August 5, 2025
D-Wave Quantum Inc. (NYSE:QBTS) is a pioneering force in the quantum computing industry, widely recognized as the first…
0 Shares
0
0
0
0
0
0
0

Biotech NewsHims & Hers (HIMS) Could 10X by 2030 — The $6.5 Billion Bull Case You Need to See

  • BioTech Health X
  • August 5, 2025
Hims & Hers Health Inc. (NYSE:HIMS) is a rapidly growing consumer-focused telehealth company on a mission to make…
0 Shares
0
0
0
0
0
0
0

Biotech NewsExicure (XCUR)’s GPC-100 Could Revolutionize Cancer Treatment – Analysts See Massive Upside for this Stock!

  • BioTech Health X
  • August 3, 2025
Exicure, Inc. (NASDAQ:XCUR) is a biotechnology company that has undergone a significant strategic transformation to focus on advancing…
0 Shares
0
0
0
0
0
0
0

Biotech NewsDRMA Stock Alert – Why Dermata Therapeutics (DRMA) Could Be the Hidden Biotech Gem of 2025!

  • BioTech Health X
  • August 3, 2025
Dermata Therapeutics, Inc. (NASDAQ:DRMA) is a clinical-stage biotechnology company focused on developing innovative and differentiated therapies for dermatological…
0 Shares
0
0
0
0
0
0
0

Biotech NewsFulcrum Therapeutics (FULC)’s Stunning Trial Results Could Make it the Next Biotech Breakout!

  • BioTech Health X
  • August 3, 2025
Fulcrum Therapeutics Inc. (NASDAQ:FULC) is a clinical-stage biopharmaceutical company dedicated to developing small-molecule therapies that target the root…
0 Shares
0
0
0
0
0
0
0

Biotech NewsFDA Decision Looms for LENZ Therapeutics (LENZ) – Analysts Predict a Huge Breakout

  • BioTech Health X
  • August 3, 2025
LENZ Therapeutics Inc. (NASDAQ:LENZ) is a clinical-stage biopharmaceutical company dedicated to addressing a significant unmet need in ophthalmology…
0 Shares
0
0
0
0
0
0
0

Biotech NewsFDA Approval Could Send Tonix Pharmaceuticals (TNXP) Soaring – Don’t Miss Out

  • BioTech Health X
  • August 3, 2025
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies that address significant…
0 Shares
0
0
0
0
0
0
0

Biotech NewsThe Secret Wall Street Play: Why Big Money Is Buying Johnson & Johnson (JNJ)

  • BioTech Health X
  • August 3, 2025
Johnson & Johnson (NYSE:JNJ) is one of the world’s most iconic and diversified healthcare companies, with a history…
0 Shares
0
0
0
0
0
0
0

Biotech NewsADMA Biologics (ADMA) Could Be the Next Billion-Dollar Biotech Superstar

  • BioTech Health X
  • August 3, 2025
ADMA Biologics Inc. (NASDAQ:ADMA) is a fast-growing biopharmaceutical company focused on the development, manufacturing, and commercialization of specialty…
0 Shares
0
0
0
0
0
0
0

Biotech NewsNovo Nordisk (NVO) Crashes – Is This the Biggest Buying Opportunity of 2025?

  • BioTech Health X
  • August 3, 2025
Novo Nordisk A/S (NYSE:NVO) is a global healthcare leader headquartered in Denmark, renowned for its pioneering work in…
0 Shares
0
0
0
0
0
0
0

Biotech News4D Molecular (FDMT): The Gene Therapy Stock With 100%+ Upside Potential

  • BioTech Health X
  • August 1, 2025
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is a clinical-stage biotechnology company dedicated to developing next-generation gene therapies using its…
0 Shares
0
0
0
0
0
0
0

Biotech NewsBio-Rad Labs (BIO) Smashes Earnings Estimates – Is the Stock Ready to Explode?

  • BioTech Health X
  • August 1, 2025
Bio-Rad Laboratories Inc. (NYSE:BIO) is a global leader in life science research and clinical diagnostics, known for its…
0 Shares
0
0
0
0
0
0
0

Biotech NewsPerformant Healthcare (PHLT) Gets $670M Buyout – Could This Be the Smartest Trade of 2025?

  • BioTech Health X
  • August 1, 2025
Performant Healthcare Inc. (NASDAQ: PHLT) is a leading provider of technology-enabled payment integrity, eligibility, and analytics services for the…
0 Shares
0
0
0
0
0
0
0

Biotech NewsWall Street Doesn’t Want You to See This Stock – Quantum (QNTM) Could Be the Next Jackpot

  • BioTech Health X
  • August 1, 2025
Quantum BioPharma Ltd. (NASDAQ:QNTM) is a biopharmaceutical company focused on developing innovative therapies for neurodegenerative and metabolic disorders,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsHarmony Biosciences (HRMY) Could Double – The Shocking Analyst Targets You Need to See

  • BioTech Health X
  • July 31, 2025
Harmony Biosciences Holdings, Inc. is a U.S.-based commercial-stage pharmaceutical company focused on developing and delivering innovative therapies for…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • PMV Pharmaceuticals (PMVP) Forecast 2026: One Mutation, One Oral Drug, and a Re-Rating That Could Hit Fast
  • Oncolytics (ONCY) Is a $90M “Science vs. Reality” Fight—And 2026 Is When Pelareorep Has to Win
  • Nkarta (NKTX)’s Plot Twist: From Cancer Chaos to Autoimmune “Immune Reset” Hype
  • Context (CNTX)’s Glow-Up: From “Old Thesis” to T-Cell Engager Chaos (In a Good Way)
  • The $290M Cancer Biotech With Phase 3 “Proof”: Candel (CADL)’s Viral Immunotherapy Isn’t Just a Science Fair Anymore
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • February 13, 2026
    PMV Pharmaceuticals (PMVP) Forecast 2026: One Mutation, One Oral Drug, and a Re-Rating That Could Hit Fast
    • February 13, 2026
    Oncolytics (ONCY) Is a $90M “Science vs. Reality” Fight—And 2026 Is When Pelareorep Has to Win
    • February 13, 2026
    Nkarta (NKTX)’s Plot Twist: From Cancer Chaos to Autoimmune “Immune Reset” Hype
    • February 13, 2026
    Context (CNTX)’s Glow-Up: From “Old Thesis” to T-Cell Engager Chaos (In a Good Way)
    • February 13, 2026
    The $290M Cancer Biotech With Phase 3 “Proof”: Candel (CADL)’s Viral Immunotherapy Isn’t Just a Science Fair Anymore
Recent Posts
  • Verastem (VSTM) Isn’t “Small-Cap Roulette” Anymore—It’s a Commercial Oncology Ramp With a 2026 Twist
    • February 13, 2026
  • The Market Cap Is Small, the Idea Is Huge: Can Allogene (ALLO) Make CAR-T as Easy as Ordering a Drug?
    • February 13, 2026
  • 44% Real-World Response? Iovance (IOVA) Just Made “Off-the-Bench” Data the New Headline
    • February 13, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (787)
  • Uncategorized (2)
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top